Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKeskin, Serkan
dc.contributor.authorKucucuk, Seden
dc.contributor.authorAk, Naziye
dc.contributor.authorAtalar, Banu
dc.contributor.authorSari, Murat
dc.contributor.authorSozen, Hamdullah
dc.contributor.authorIbis, Kamuran
dc.contributor.authorTopuz, Samet
dc.contributor.authorSaip, Pinar
dc.date.accessioned2025-10-16T15:24:32Z
dc.date.issued2019
dc.identifier.doi10.1159/000494334
dc.identifier.otherWOS:000462040500003
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8122
dc.publisherKARGER
dc.sourceONCOLOGY RESEARCH AND TREATMENT
dc.subjectOvarian carcinoma
dc.subjectBrain metastasis
dc.subjectSurvival
dc.subjectPrognostic factors
dc.titleSurvival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS